Andy Batts
Long only, value, growth, momentum

Integra LifeSciences: An Evolving Global Leader In Bionics

Integra LifeSciences (NASDAQ:IART), a global medical bionic implant company, disclosed last week that the U.S. Food and Drug Administration successfully completed an inspection of its regenerative medicine facility in Plainsboro, New Jersey. The FDA issued a warning letter to the company after inspecting its Plainsboro facility in the third quarter of 2011. At the conclusion of the recent inspection, the FDA found that the company had addressed the issues raised in the warning letter and previous inspectional observations, and it issued no further inspectional observations.

Integra's stock underperformed the market and its peers due to the FDA warning. Now in the absence of any warning the stock is poised to scale higher. In this article I will focus

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details